Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Julie Denny
  • December 19, 2013
  • Articles

Patients in China: the Silent Stakeholder

Patients in China: the Silent Stakeholder

Published in eyeforpharma 25 November 2013 by Mary Assimakopoulos

This month Mary Assimakopoulos, talks about the issues around healthcare access for patients in China and highlights some of the adherence issues unique to the region.

read more »

  • Posted by Claire Richardson
  • December 17, 2013
  • Webinars

Observational Research

Observational Research

Presenting a window on the world of your customer

Healthcare customers are changing. Marketers now need to understand the needs of many stakeholders, from patients and carers, to physicians, nurses and payers, amongst others, as well as the many channels of communication they are exposed to and utilise in both their work and home lives.
At Research Partnership we have been exploring the benefits of using Observational Research approaches, where the interviewer is less visible to the respondent, as a means of digging deeper and getting a more real, less 'contaminated' insight into the world of your customers.

read more »

  • Posted by Olivia Richardson
  • December 17, 2013
  • News

Annual donation made to Forever Angels baby home

As in previous years, Research Partnership has made a seasonal donation to its chosen charity, Forever Angels this week of US$2,000.

As in previous years, Research Partnership has made a seasonal donation to its chosen charity, Forever Angels this week of US$2,000.
Thanks to the incredible efforts of our staff, we also raised a further $1,700 for the charity through various fundraising activities, bringing our total donation this winter to $3,700. Employees across our 6 offices have been partaking in various fundraising initiatives throughout 2013 to raise money for this worthy cause, including “Come dine with RP”, “The Great RP Bake Off” and “Cash in the RP Attic” events.

read more »

  • Posted by Julie Denny
  • December 9, 2013
  • News

Study reveals that 79% of RA patients would prefer oral tablet treatment

Study reveals that 79% of RA patients would prefer oral tablet treatment

Pfizer and Research Partnership presented the poster “Patient preferences for oral versus injectable and intravenous methods for Rheumatoid Arthritis” at ISPOR 16th Annual European Congress, 2-6 November in Dublin.

The poster, co-authored by Director Sue Marett and Research Manager Nicky Barclay, investigated RA patient administration preferences utilising data from a recent study conducted by Research Partnership for Pfizer.

read more »

  • Posted by Julie Denny
  • December 3, 2013
  • News

Brand leaders in RA will lose market share, predict rheumatologists

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

In a recent study, physicians predicted that current market leaders Enbrel (etanercept) and Humira (adalimumab) will continue to lose market share to newer biologics such as RoActemra (tocilizumab), Orencia (abatacept) and Simponi (golimumab) and may experience strong competition from biosimilar agents and pipeline products with novel mechanisms of action, including small molecules.

read more »